Topic: Abraxis Bioscience Inc.

Biotech's Soon-Shiong Nabs Another Billion

Forbes - 585 days ago
Patrick Soon-Shiong, the richest man in the drug business, just got even richer. When we last valued his Abraxis stake, it was worth $1.2 billion less than this. If the drug is approved for lung cancer with certain claims by April 1, ...

Abraxis Finds The Right Dose

Forbes - 691 days ago
Abraxis Bioscience gained 28.6% on Thursday after the drugmaker announced its lung cancer treatment Abraxane met the goals of its late-stage study.. According to Abraxis ( ABII - news - people ), the study, which had 1,052 non-small cell lung carcinoma patients ...